Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

315 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecular detection of breast cancer metastasis in sentinel lymph nodes by reverse transcriptase polymerase chain reaction (RT-PCR): identifying, evaluating and establishing multi-marker panels.
Wallwiener CW, Wallwiener M, Kurth RR, Röhm C, Neubauer H, Banys MJ, Staebler A, Schönfisch B, Meuer SC, Giese T, Fehm TN. Wallwiener CW, et al. Among authors: kurth rr. Breast Cancer Res Treat. 2011 Dec;130(3):833-44. doi: 10.1007/s10549-011-1710-0. Epub 2011 Aug 21. Breast Cancer Res Treat. 2011. PMID: 21858660
Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma.
Lengerke C, Fehm T, Kurth R, Neubauer H, Scheble V, Müller F, Schneider F, Petersen K, Wallwiener D, Kanz L, Fend F, Perner S, Bareiss PM, Staebler A. Lengerke C, et al. Among authors: kurth r. BMC Cancer. 2011 Jan 28;11:42. doi: 10.1186/1471-2407-11-42. BMC Cancer. 2011. PMID: 21276239 Free PMC article.
[A rare cause of thyreotoxicosis].
Sauer-Schulz A, Müssig K, Kurth R, Fend F, Teichmann R, Schnauder G. Sauer-Schulz A, et al. Among authors: kurth r. Dtsch Med Wochenschr. 2010 Sep;135(37):1798. doi: 10.1055/s-0030-1247616. Epub 2010 Sep 7. Dtsch Med Wochenschr. 2010. PMID: 20824601 German.
Author Correction: Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations.
Miyazaki I, Odintsov I, Ishida K, Lui AJW, Kato M, Suzuki T, Zhang T, Wakayama K, Kurth RI, Cheng R, Fujita H, Delasos L, Vojnic M, Khodos I, Yamada Y, Ishizawa K, Mattar MS, Funabashi K, Chang Q, Ohkubo S, Yano W, Terada R, Giuliano C, Lu YC, Bonifacio A, Kunte S, Davare MA, Cheng EH, de Stanchina E, Lovati E, Iwasawa Y, Ladanyi M, Somwar R. Miyazaki I, et al. Among authors: kurth ri. Nat Cancer. 2023 Oct;4(10):1526. doi: 10.1038/s43018-023-00663-3. Nat Cancer. 2023. PMID: 37814012 Free PMC article. No abstract available.
315 results